Effect of propranolol on heart rate variability in patients with end-stage renal disease: A double-blind, placebo-controlled, randomized crossover pilot trial

Clinical Nephrology

Volumn 61, Issue 5, 2004, Pages 316-323

  Tory, Kalman ^a   Horvath E ^a   Suveges Z ^a   Fekete, A ^a   Sallay, P ^a   Berta, K ^a   Szabo T ^a   Szabo A J ^a   Tulassay, T ^a   Reusz, G S ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Autonomic nervous system; Heart rate variability; Renal failure; Sympathetic overactivity; Uremia

Indexed keywords

ADRENALIN; AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE; ENALAPRIL; METOPROLOL; NIFEDIPINE; NORADRENALIN; PLACEBO; PROPRANOLOL;

ADRENALIN BLOOD LEVEL; ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOPAMINE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFECT; ELECTROCARDIOGRAM; FEMALE; HEART ARRHYTHMIA; HEART RATE VARIABILITY; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MALE; NORADRENALIN BLOOD LEVEL; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SUPINE POSITION; SYMPATHETIC TONE; UREMIC POLYNEUROPATHY; VAGUS NERVE STIMULATION;

EID: 2342453195     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP61316     Document Type: Article

References (35)

1. Akselrod S 1995 Components of heart rate variability. In: Malik M, Camm AJ (eds) Heart Rate Variability. Futura, New York, pp 147-165
2. Armengol NE, Amenós AC, Illa MB, Bertran GJ, Ginesta CJ, Fillat RF 1997 Autonomic nervous system and adrenergic receptors in chronic hypotensive haemodialysis patients. Nephrol Dial Transplant 12: 939-944
3. Boero R, Pignataro A, Ferro M, Quarello F 2001 Sympathetic nervous system and chronic renal failure. Clin Exp Hypertens 23: 69-75
4. Candito M, Albertini M, Politano, Deville A, Mariani R, Chambon P 1993 Plasma catecholamine levels in children. J Chromatography 617: 304-307
5. Cashion AK, Cowan PA, Milstead EJ, Gaber AO, Hathaway DK 2000 Heart rate variability, mortality, and exercise in patients with end-stage renal disease. Prog Transplant 10: 10-16
6. Corder CN, Sharma J, McDonald RH 1980 Variable levels of plasma catecholamines and dopamine betahydroxylase in hemodialysis patients. Nephron 25: 267-272
7. Elias AN, Vaziri ND, Maksy M 1985 Plasma norepinephrine, epinephrine and dopamine levels in end-stage renal disease. Effect of hemodialysis. Arch Intern Med 145: 1013-1015
8. Ewing DJ, Winney R 1975 Autonomic function in patients with chronic renal failure on intermittent hemodialysis. Nephron 15: 424-429
9. Hayano J, Takahashi H, Toriyama T, Mukai S, Okada A, Sakata S, Yamada A, Ohte N, Kawahara H 1999 Prognostic value of heart rate variability during long-term follow-up in chronic haemodialysis patients with end-stage renal disease. Nephrol Dial Transplant 14: 1480-1488
10. Heidbreder E, Schafferhans K, Heidland A 1985 Disturbances of peripheral and autonomic nervous system in chronic renal failure: effects of hemodialysis and transplantation. Clin Nephrol 23: 222-228
11. Henry WL, Ware J, Gardin JM, Hepner SI, McKay J, Weiner M 1978 Echocardiographic measurements in normal subjects. Growth-related changes that occur between infancy and early adulthood. Circulation 57: 278-285
12. Jassal SV, Coulshed SJ, Douglas JF, Stout RW 1997 Autonomic neuropathy predisposing to arrhythmias in hemodialysis patients. Am J Kidney Dis 30: 219-223
13. Kurata C, Uehara A, Sugi T, Ishikawa A, Fujita K, Yonemura K, Hishida A, Ishikawa K, Tawarahara K, Shouda S, Mikami T 2000 Cardiac autonomic neuropathy in patients with chronic renal failure on hemodialysis. Nephron 84: 312-319
14. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ 1998 Baroreflex sensitivity and heart rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 351: 478-484
15. Lampert R, Ickovics JR, Viscoli CJ, Horwitz RI, Lee FA 2003 Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial. Am J Cardiol 91: 137-142
16. Lefrandt JD, Heitmann J, Sevre K, Castellano M, Hausberg M, Fallon M, Fluckiger L, Urbigkeit A, Rostrup M, Agabiti-Rosei E, Rahn KH, Murphy M, Zannad F, de Kam PJ, van Roon AM, Smit AJ 2001 The effects of dihydropyridine and phenylalkylamine calcium antagonist classes on autonomic function in hypertension: the VAMPHYRE study. Am J Hypertens 14: 1083-1089
17. Ligtenberg G, Blankestijn PJ, Oey PL, Klein IH, Dijkhorst-Oei LT, Boomsma F, Wieneke GH, van Huffelen AC, Koomans HA 1999 Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med 340: 1360-1361
18. Lombardi F 2000 Chaos theory, heart rate variability, and arrhythmic mortality. Circulation 101: 8-10
19. Malik M, Bigger JT, Camm AJ and the Task Force of The European Society of Cardiology and The North American Society of Pacing and Electrophysiology 1996 Heart rate variability. Standards of measurement, physiological interpretation and clinical use. Circulation 93: 1043-1065
20. Mallamaci E, Zoccali C, Ciccarelli M, Briggs D 1986 Autonomic function in uremic patients treated by hemodialysis or CAPD and in transplant patients. Clin Nephrol 25: 175-180
21. Nicholson JF, Pesce MA 1995 Laboratory examinations and reference values in infants and children. In: Behrman RE, Kliegman RM, Arvin AM, Nelson WE (eds) Textbook of Pediatrics (15th edn). WB Saunders, Philadelphia, p 2038
22. Notarius CF, Butler GC, Akdo S, Pollard MJ, Senn BL, Floras JS 1999 Dissocication between microneurographic and heart rate variability estimates of sympathetic tone in normal subjects and patients with heart failure. Clin Sci 96: 557-565
23. O'Brien E, Raeber A, Parati G, Staessen J, Myers MG 2001 Blood pressure measuring devices: recommendations of the European Society of Hypertension. BMJ 322: 531-536
24. Omboni S, Parati G, Di Rienzo M, Wieling W, Mancia G 1996 Blood pressure and heart rate variability in autonomic disorders: a critical review. Clin Auton Res 6: 171-182
25. Rubinger D, Sapoznikov D, Pollak A, Popovtzer MM, Luria MH 1999 Heart rate variability during chronic hemodialysis and after renal transplantation: studies in patients without and with systemic amyloidosis. J Am Soc Nephrol 10: 1972-1981
26. Rump LC, Amann K, Orth S, Ritz E 2000 Sympathetic overactivity in renal disease: a window to understand progression and cardiovascular complications of uraemia? Nephrol Dial Transplant 15: 1735-1738
27. Schwartz GJ, Gauthier B 1985 A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr 106: 522-526
28. Shaw LW 1981 Effects of a prescribed supervised exercise program on mortality and cardiovascular morbidity in patients after myocardial infarction. The National Exercise and Heart Disease Project. Am J Cardiol 48: 39-46
29. Soergel M, Kirschstein M, Busch C, Danne T, Gellermann J, Holl R, Krull F, Reichert H, Reusz GS, Rascher W 1997 Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr 130: 178-184
30. Taylor JA, Myers CW, Halliwill JR 2001 Sympathetic restraint of respiratory sinus arrhythmia: implications for vagal-cardiac tone assessment in humans. Am J Physiol Heart Circ Physiol 280: H2804-2814
31. Tory K, Sallay P, Tóth-Heyn P, Szabó Att, Szabó And, Tulassay T, Reusz GS 2001 Signs of autonomic neuropathy in childhood uremia. Pediatr Nephrol 16: 25-28
32. Vaile JC, Fletcher J, Al-Ani M, Ross HF, Littler WA, Coote JH, Townend JN 1999 Use of opposing reflex stimuli and heart rate variability to examine the effects of lipophilic and hydrophilic beta-blockers on human cardiac vagal control. Clin Sci 97: 609-610
33. Vita G, Bellingheri G, Trusso A, Costantino G, Santoro D, Monteleone F, Messina C, Savica V 1999 Uremic autonomic neuropathy studied by spectral analysis of heart rate. Kidney Int 56: 232-237
34. Ziegler M, Kennedy A, Morrissey E, O'Connor DT 1990 Norepinephrine clearance, chromogranin A and dopamine â hydroxylase in renal failure. Kidney Int 37: 1357-1362
35. Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Cataliotti A, Stancanelli B, Malatino LS, Cateliotti A 2002 Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 105: 1354-1359